Tag: Protein kinase inhibitor

Tag Visualization: Top 50 related tags by occurrence

Recent Related Articles to Protein kinase inhibitor

Exelixis/Roche combo fails to improve overall survival in NSCLC - PharmaLive

Added to Collection on: 2022-12-10 04:29:34

Tags for this article:

Cancer
Clinical medicine
Antineoplastic drugs
Lung cancer
Neoplasms
Genentech
Cabozantinib
Cyclopropanes
Exelixis
Atezolizumab
Protein kinase inhibitor
Non-small-cell lung carcinoma

Click the tags to see associated articles and topics

View Article Details
TOP NEWS: AstraZeneca wins approvals for cancer treatments in Japan - Shares Magazine

Added to Collection on: 2022-12-28 08:12:40

Tags for this article:

RTT
Cancer
Monoclonal antibodies
Medical specialties
Medicine
Oncology
AstraZeneca
Durvalumab
Protein kinase inhibitor
Leukemia
Treatment of cancer
Chronic lymphocytic leukemia
AstraZeneca plc
Japan

Click the tags to see associated articles and topics

View Article Details
TOP NEWS: AstraZeneca wins approvals for cancer treatments in Japan - shareprices.com

Added to Collection on: 2022-12-28 07:57:09

Tags for this article:

RTT
Companies
Cancer
Monoclonal antibodies
AstraZeneca
Södertälje Municipality
Medical specialties
Oncology
Durvalumab
Protein kinase inhibitor
Chronic lymphocytic leukemia
Leukemia
AstraZeneca plc
Alliance News Ltd.
Japan

Click the tags to see associated articles and topics

View Article Details
Updates: MET targeted therapy for EXON 14 mutations in lung cancer - EurekAlert!

Added to Collection on: 2023-09-12 13:58:34

Tags for this article:

Breakthrough therapy
Lung cancer
Orphan drugs
Antineoplastic drugs
Chloroarenes
Crizotinib
Non-small-cell lung cancer
Capmatinib
Tyrosine kinase
Protein kinase inhibitor
Tepotinib
ROS1

Click the tags to see associated articles and topics

View Article Details
J&J's Rybrevant in Combo with Lazertinib Clears Phase III in NSCLC - BioSpace

Added to Collection on: 2023-09-28 20:03:05

Tags for this article:

Lung cancer
Breakthrough therapy
Tyrosine kinase inhibitors
Ethers
T790M
Non-small-cell lung cancer
Epidermal growth factor receptor
Amivantamab
Bispecific monoclonal antibody
Protein kinase inhibitor
Osimertinib
Draft:Lazertinib
Johnson & Johnson

Click the tags to see associated articles and topics

View Article Details
Non-Small Cell Lung Cancer Pipeline Drugs Analysis Report, 2023 - Digital Journal

Added to Collection on: 2023-12-04 20:50:49

Tags for this article:

Lung cancer
KRAS
Genmab
Targeted therapy
Small-cell carcinoma
Seagen
Non-small-cell lung cancer
Protein kinase inhibitor
Cancer
Treatment of lung cancer
G1 Therapeutics
Non-Small Cell Lung Cancer

Click the tags to see associated articles and topics

View Article Details
Cancer biotech ArriVent Biopharma files for a $100 million IPO - Renaissance Capital

Added to Collection on: 2024-01-05 21:48:51

Tags for this article:

Lung cancer
Quinazolines
Oncogenes
Tyrosine kinase receptors
Tyrosine-kinase inhibitor
Antineoplastic drugs
Epidermal growth factor receptor
Non-small-cell lung cancer
Protein kinase inhibitor
Afatinib
T790M

Click the tags to see associated articles and topics

View Article Details
ArriVent's Nasdaq Debut Nabs $175M as Signs Indicate an Opening IPO Window

Added to Collection on: 2024-01-26 16:48:04

Tags for this article:

Tyrosine kinase receptors
Epidermal growth factor receptor
Non-small-cell lung cancer
RET proto-oncogene
Amivantamab
Protein kinase inhibitor
Anaplastic lymphoma kinase
Lung cancer
ArriVent BioPharma

Click the tags to see associated articles and topics

View Article Details
Cardio-Oncology Is a Growing Subspecialty, but Where Are the Oncologists

Added to Collection on: 2024-02-05 16:47:40

Tags for this article:

Antineoplastic drugs
Cancer treatments
Immunology
HER2
Trastuzumab
Targeted therapy
Protein kinase inhibitor
Tyrosine-kinase inhibitor
Chemotherapy

Click the tags to see associated articles and topics

View Article Details
Iambic begins dosing in trial of IAM1363 for HER2-driven cancer

Added to Collection on: 2024-03-28 12:20:56

Tags for this article:

Tyrosine kinase receptors
Antineoplastic drugs
Breast cancer
HER2
Epidermal growth factor receptor
Triple-negative breast cancer
Trastuzumab
Tyrosine-kinase inhibitor
Protein kinase inhibitor
Lapatinib
Afatinib

Click the tags to see associated articles and topics

View Article Details